Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Third Quarter Trading Statement

27 Oct 2011 07:00

RNS Number : 9104Q
Croda International PLC
27 October 2011
 



27 October 2011

 

Croda International Plc

 

Third Quarter Trading Statement

 

Commenting on trading for the quarter ended 30 September 2011, Martin Flower, Chairman of Croda International Plc, said:

 

"I am pleased to report good turnover and profit progress in the third quarter, driven by sales growth and margin improvement in our core businesses.

 

For the three months ended 30 September 2011, Group sales from continuing operations increased 5.1% to £265.6m (2010: £252.6m). In most business areas we saw an improving trend during the quarter.

 

Operating profit from continuing operations increased 18.3% to £57.6m (2009: £48.7m). Interest costs fell, resulting in continuing pre-tax profit increasing 20.8% to £57.4m (2010: £47.5m).

Year-to-date, the pre-tax profit from continuing operations is up 27.1% at £182.2m (2010: £143.4m).

 

Consumer Care continued to trade strongly in the third quarter, reporting a significant increase in sales (+13.6%) and operating profit (+30.8%) and improved margins versus the corresponding quarter in 2010. Sales and operating profits in all business areas within Consumer Care were well ahead of 2010.

 

Industrial Specialities turnover declined 3.5% against the tough comparatives of a particularly strong third quarter in 2010. The shortfall was in July, with sales in the rest of the period ahead of 2010. Operating profit was down 6.8% with a decrease in commodity and by-product profitability being partially mitigated by stronger performances elsewhere in the sector.

 

Net debt reduced by £15.5m to £237.8m in the quarter (2010: £240.7m) despite completing the £50m buyback programme in the period.

 

Croda continues to trade well and we expect to report further progress in the final quarter and into 2012."

 

For further information please contact:

 

Mike Humphrey

Group Chief Executive

01405 860551

Sean Christie

Group Finance Director

01405 860551

Charlie Armitstead

FTI Consulting

020 7269 7176

 

 

The company will host a conference call for analysts at 8.00am today.

 

Please dial +44 (0)1452 562 815 and quote "Croda International" to gain access to the call.

 

Additional Information

 

 

 

 

 

£m

Q3

9 months

2011

2010

2011

2010

Consumer Care

145.6

128.2

+13.6%

439.2

392.6

+11.9%

Industrial Specialities

120.0

124.4

-3.5%

386.0

371.9

+3.8%

Continuing turnover

265.6

252.6

+5.1%

825.2

764.5

+7.9%

Consumer Care

42.5

32.5

+30.8%

130.5

103.6

+26.0%

Industrial Specialities

15.1

16.2

-6.8%

52.4

45.6

+14.9%

Continuing operating profit

57.6

48.7

+18.3%

182.9

149.2

+22.6%

Operating margin

 

21.6%

 

19.3%

 

 

 

22.2%

 

19.5%

 

 

 

Interest

(0.2)

(1.2)

(0.7)

(5.8)

Continuing pre tax profit

57.4

47.5

+20.8%

182.2

143.4

+27.1%

 

 

 

 

Analysis of Q3 turnover uplift

Price/mix

+18.4%

Volume

-14.8%

Currency translation

+1.5%

Continuing turnover increase

+5.1%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMFBATMBJTBIB
Date   Source Headline
11th Feb 20111:38 pmRNSDirector/PDMR Shareholding
12th Jan 201110:43 amRNSDirector/PDMR Shareholding
21st Dec 201011:39 amRNSDirector/PDMR Shareholding
13th Dec 20104:39 pmRNSDirector/PDMR Shareholding
7th Dec 20105:24 pmRNSDirector/PDMR Shareholding
11th Nov 20105:14 pmRNSDirector/PDMR Shareholding
2nd Nov 201010:27 amRNSDirector/PDMR Shareholding
28th Oct 201010:24 amRNSHolding(s) in Company
28th Oct 20107:00 amRNSQ3 Trading Statement
13th Oct 20105:20 pmRNSDirector/PDMR Shareholding
7th Oct 20104:39 pmRNSDirector/PDMR Shareholding
22nd Sep 20103:26 pmRNSDirector/PDMR Shareholding
17th Sep 20109:50 amRNSDirector/PDMR Shareholding
13th Sep 20102:56 pmRNSDirector/PDMR Shareholding
9th Sep 20107:00 amRNSSite Visit
12th Aug 201011:25 amRNSDirector/PDMR Shareholding
28th Jul 20104:29 pmRNSHolding(s) in Company
27th Jul 20107:00 amRNSInterim Results
15th Jul 201011:29 amRNSHolding(s) in Company
13th Jul 20103:32 pmRNSDirector/PDMR Shareholding
1st Jul 20107:00 amRNSBoard Appointments
1st Jul 20107:00 amRNSCompletion of Sale
14th Jun 20104:35 pmRNSDirector/PDMR Shareholding
8th Jun 201012:15 pmRNSDirector/PDMR Shareholding
20th May 20104:37 pmRNSDirector/PDMR Shareholding
11th May 20102:39 pmRNSDirector/PDMR Shareholding
10th May 20107:00 amRNSSale of German Oleochemicals Business
7th May 20103:35 pmRNSHolding(s) in Company
30th Apr 20103:10 pmRNSDirector/PDMR Shareholding
30th Apr 201011:54 amRNSHolding(s) in Company
28th Apr 20105:04 pmRNSResult of AGM
28th Apr 20107:00 amRNSQ1 2010 Trading Statement
13th Apr 20104:57 pmRNSDirector/PDMR Shareholding
8th Apr 20102:08 pmRNSAnnual Information Update
29th Mar 20104:53 pmRNSDirector/PDMR Shareholding
25th Mar 20105:03 pmRNSHolding(s) in Company
25th Mar 20102:15 pmRNSAnnual Financial Report
23rd Mar 20105:03 pmRNSDirector/PDMR Shareholding
17th Mar 20101:39 pmRNSDirector/PDMR Shareholding
11th Mar 20104:34 pmRNSDirector/PDMR Shareholding
9th Mar 20104:52 pmRNSDirector/PDMR Shareholding
5th Mar 20102:08 pmRNSTotal Voting Rights
5th Mar 20102:07 pmRNSTransaction in Own Shares
2nd Mar 201012:20 pmRNSDirector/PDMR Shareholding
25th Feb 20104:18 pmRNSDirector/PDMR Shareholding
24th Feb 20104:22 pmRNSDirector/PDMR Shareholding
23rd Feb 20107:00 amRNSFinal Results
11th Feb 20102:51 pmRNSDirector/PDMR Shareholding
13th Jan 20109:07 amRNSDirector/PDMR Shareholding
11th Dec 20094:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.